NRobotics Co

NRobotics Co Debt/EBITDA

The Total Debt to EBITDA Ratio of NRobotics Co (138360.KQ) as of Oct 16, 2026 is -7.13. In the previous year, Total Debt to EBITDA Ratio was 26.73 — a change of -126.68% (lower).

Debt/EBITDA

-7.13

YoY

-126.68%

Last updated:

Total Debt to EBITDA Ratio of NRobotics Co is 2024 -7.13 . Total Debt to EBITDA Ratio of NRobotics Co was 2023 26.73 . It decreases by -126.68% lower compared to the previous year.

The NRobotics Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2015
0.25 KRW
Jan 1, 2016
0.33 KRW
Jan 1, 2017
39.53 KRW
Jan 1, 2018
-2.39 KRW
Jan 1, 2019
26.41 KRW
Jan 1, 2020
-0.03 KRW
Jan 1, 2021
26.73 KRW
Jan 1, 2024
-7.13 KRW
The NRobotics Co Debt/EBITDA history
YEARDebt/EBITDAYoY
-7.13-126.68%
26.73-99,446.29%
-0.03-100.10%
26.41-1,206.84%
-2.39-106.04%
39.53+11,912.43%
0.33+32.73%
0.25+3,769.09%
0.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NRobotics Co Stock analysis

What does NRobotics Co do? NRobotics Co Ltd, trading under the ticker symbol 138360.KQ and identified by the ISIN KR7138360003, is a South Korean enterprise operating within the Materials sector, specifically in the Chemicals industry. The company maintains its corporate headquarters in Siheung, located in the Gyeonggi-Do province. As of the most recent data, the organization employs a workforce of 45 full-time staff members, reflecting its status as a small-to-medium sized entity in the chemical manufacturing landscape. NRobotics Co Ltd officially entered the public markets through an initial public offering on November 8, 2013, marking a significant milestone in its corporate history and financial transparency. The company’s primary business activity revolves around the manufacture and sale of cosmetic ingredients, serving a diverse range of clients in the beauty and personal care industries. Its product portfolio is extensive and technologically advanced, featuring bioconversion technology products, encapsulated products, natural extracts, and synthetic compounds. Among its notable offerings are specialized formulations such as Aquatouch L, a blend composed of glycerin, dimethicone, water, and lecithin, designed to enhance skin hydration and texture. Another key product is Silkytouch L, which combines water, dimethicone, glycerin, palmitoyl inulin, behenyl alcohol, and 1,2-hexanediol to provide smooth application and sensory benefits. The company also produces a range of phyto-based ingredients, including Phytoact Reliefer, which utilizes phaseolus radiates seed extract and avena sativa meal extract, alongside other active components like ethyhexylglycerin. Further innovations in the natural extract segment include Actosome InoCeramide E06, Actosome Retinol850, Actosome Retinal Palmitate, Actostem GinElixir, and Actosome Deage, each targeted at specific cosmetic efficacy needs such as anti-aging and skin barrier support. In addition to its core cosmetic ingredient business, NRobotics Co Ltd has diversified its operations to include the provision of electronic materials, indicating a strategic expansion into adjacent high-tech sectors. This diversification underscores the company’s commitment to leveraging its chemical expertise across multiple industrial applications. Despite its relatively small employee base, the company’s focus on specialized, high-value ingredients and its presence in both cosmetic and electronic material markets position it as a niche player with potential for growth in specialized chemical supply chains. The company’s official web presence can be accessed at http://www.hjfm.co.kr/, where stakeholders and potential partners can find further details regarding its operations and product lines. NRobotics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NRobotics Co stock

Total Debt to EBITDA Ratio of NRobotics Co is -7.13 in 2024.

Total Debt to EBITDA Ratio of NRobotics Co changed from 26.73 to -7.13, representing a -126.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio NRobotics Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's NRobotics Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — NRobotics Co

All Key Metrics — NRobotics Co